Reproductive health

Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company

Retrieved on: 
Monday, November 7, 2022

Fulgent Pharma and Fulgent Genetics were previously both owned by Fulgent Therapeutics until 2016, when the businesses were separated ahead of the Initial Public Offering of Fulgent Genetics.

Key Points: 
  • Fulgent Pharma and Fulgent Genetics were previously both owned by Fulgent Therapeutics until 2016, when the businesses were separated ahead of the Initial Public Offering of Fulgent Genetics.
  • Fulgent Genetics track record of integrating acquisitions, strategic partnerships, and disciplined execution has been a key element in the companys growth.
  • Fulgent Genetics is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health.
  • In 2016, Fulgent Therapeutics split into two separate entities - Fulgent Pharma and Fulgent Genetics - in order to better pursue their independent objectives.

Talis Biomedical Reports Third Quarter 2022 Financial Results

Retrieved on: 
Thursday, November 3, 2022

REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today reported financial results for the third quarter ended September 30, 2022.

Key Points: 
  • REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today reported financial results for the third quarter ended September 30, 2022.
  • To align resources with this new focus, Talis implemented a 35 percent reduction in force and additional cost-saving measures in the third quarter.
  • The company expects to start realizing the benefit of its restructuring plan in the fourth quarter of 2022.
  • Talis plans to provide progress updates as they are achieved or available and will not be hosting a conference call to discuss third quarter results.

Amazon and USAID Launch Effort to Boost Climate Funding for Women

Retrieved on: 
Thursday, November 3, 2022

Amazon will commit a total of $53 million to help accelerate womens climate solutions, including $3 million toward the USAID partnership and $50 million for Amazon to invest directly in climate tech companies run by women.

Key Points: 
  • Amazon will commit a total of $53 million to help accelerate womens climate solutions, including $3 million toward the USAID partnership and $50 million for Amazon to invest directly in climate tech companies run by women.
  • Amazon will serve as a founding partner of USAIDs Climate Gender Equity Fund, a new climate finance facility designed to remove systemic market barriers that prevent women and girls from accessing climate finance.
  • The Climate Gender Equity Fund will have a global focus and provide grants for businesses, NGOs, accelerators, incubators, and grassroots organizations working on women-led climate solutions.
  • Working with Elemental Excelerator , a climate tech startup accelerator that is a leader in promoting diversity, equity, and inclusion principles in climate tech.

UN Foundation Honors Global Changemakers at 'We the Peoples' Awards Ceremony

Retrieved on: 
Friday, November 4, 2022

NEW YORK, Nov. 3, 2022 /PRNewswire-PRWeb/ -- The United Nations Foundation announced today the recipients of its annual Global Leadership Awards, which recognize extraordinary individuals and organizations whose work embodies the values and purposes of the UN: to create a safer, healthier, and fairer world for everyone, everywhere.

Key Points: 
  • "As we gather this year amid a series of complex global crises, I'm reminded of an unassailable truth: our progress is a choice," said Elizabeth Cousens, President and CEO of the UN Foundation.
  • "The leaders, changemakers, and organizations we are recognizing tonight are choosing progress every day, and reminding us that there is power in cooperation.
  • In addition to the exceptional individuals recognized with the Global Champion for Change and SDG Vanguard Awards, each year the UN Foundation also honors the compassion, courage, and determination of UN frontline workers with the UN Heroes Award.
  • Founded in 1998 by entrepreneur and philanthropist Ted Turner, the UN Foundation works with philanthropic, corporate, government, and individual and civil society partners around the world.

The National Birth Equity Collaborative Partners With Cortavo for Managed IT and Cybersecurity

Retrieved on: 
Thursday, November 3, 2022

ATLANTA, Nov. 3, 2022 /PRNewswire-PRWeb/ -- The National Birth Equity Collaborative (NBEC) has embarked on a partnership with the Atlanta-based managed IT service provider Cortavo for its managed IT solutions. Cortavo was founded to help small to mid-sized businesses by providing complete and affordable IT solutions. Their mission is to remove the complexity of business IT and provide everything businesses need to be successful, from cybersecurity, unlimited service desk support, hybrid workplace solutions, office connectivity, cloud data storage, hardware and software. Cortavo's all-inclusive IT plans and support are designed to scale with businesses as they grow.

Key Points: 
  • National Birth Equity Collaborative partnered with Cortavo, a managed IT services provider, to help their organization handle their growth and become more effective in their mission.
  • ATLANTA, Nov. 3, 2022 /PRNewswire-PRWeb/ -- The National Birth Equity Collaborative (NBEC) has embarked on a partnership with the Atlanta-based managed IT service provider Cortavofor its managed IT solutions.
  • Cortavo was founded to help small to mid-sized businesses by providing complete and affordable IT solutions.
  • The National Birth Equity Collaborative (NBEC) is a fiscally sponsored program of the The Praxis Project, a 501(c)(3) public charity.

READY, HEALTHY & ABLE: HealthyWomen Launches New Program to Provide Servicewomen and Healthcare Providers Content and Resources to Take Control of Their Health

Retrieved on: 
Thursday, November 3, 2022

The U.S. military has never before had a higher percentage of women, yet military healthcare services have not evolved to reflect this changing population.

Key Points: 
  • The U.S. military has never before had a higher percentage of women, yet military healthcare services have not evolved to reflect this changing population.
  • The first phase of the Ready, Healthy & Able program will address this lack of gender-specific healthcare resources, especially in the areas of reproductive, urologic and mental health.
  • Elevate understanding and awareness of women's health conditions and women-focused healthcare services within the military branches among servicewomen and service members with female biology.
  • In addition to direct outreach to servicewomen and service members with female biology, this program also aims to provide the military healthcare community with the resources it needs to provide optimal care.

XWELL Celebrates Opening of New Treat Location at Salt Lake City International Airport

Retrieved on: 
Wednesday, November 2, 2022

As innovators of wellness solutions, we are thrilled to celebrate the opening of our third Treat location, said XWELL chief executive officer Scott Milford.

Key Points: 
  • As innovators of wellness solutions, we are thrilled to celebrate the opening of our third Treat location, said XWELL chief executive officer Scott Milford.
  • The opening of this new site in Salt Lake City reaffirms XWELLs commitment to the Companys transformation and growth.
  • The addition of Salt Lake City marks the third brick-and-mortar location of Treat.
  • XWELL currently operates two other Treat locations in Terminal 4 of John F. Kennedy International Airport in New York City and in Terminal 4 of Sky Harbor International Airport in Phoenix, Arizona.

New Clinical Trial Finds Seed's Pediatric Synbiotic PDS-08™ Impacts Gut Microbiome and Bowel Movements in Children

Retrieved on: 
Wednesday, November 2, 2022

LOS ANGELES, Nov. 2, 2022 /PRNewswire/ -- Seed Health, a microbiome science company pioneering innovations in probiotics, today announced the publication of a double-blind, placebo-controlled clinical study in Pediatric Research (Nature Portfolio) –– the official journal of the American Pediatric Society, the European Society for Paediatric Research, and the Society for Pediatric Research. The study demonstrates the clinical potential of Seed Health's first pediatric synbiotic offering, PDS-08™ Pediatric Daily Synbiotic, in children with intermittent constipation. Christopher E. Mason, Ph.D., Professor of Physiology and Biophysics at Weill Cornell Medicine, led the bioinformatics analysis, including the generation of novel insights into the role of the gut microbiome in pediatric gastrointestinal (GI) health.

Key Points: 
  • The study demonstrates the clinical potential of Seed Health's first pediatric synbiotic offering, PDS-08 Pediatric Daily Synbiotic , in children with intermittent constipation.
  • Children with intermittent constipation (less than five weekly bowel movements, or WBMs) experienced an increase in regular, healthy WBMs while taking PDS-08 .
  • "These findings represent the next frontier in probiotics and deepen our understanding of the pediatric gut microbiome."
  • LUCA Biologics , Seed Health's biotechnology company co-founded with Dr. Jacques Ravel, develops living medicines targeting the vaginal microbiome for urogenital and reproductive health.

New Clinical Trial Finds Seed's Pediatric Synbiotic PDS-08™ Impacts Gut Microbiome and Bowel Movements in Children

Retrieved on: 
Wednesday, November 2, 2022

LOS ANGELES, Nov. 2, 2022 /PRNewswire/ -- Seed Health, a microbiome science company pioneering innovations in probiotics, today announced the publication of a double-blind, placebo-controlled clinical study in Pediatric Research (Nature Portfolio) –– the official journal of the American Pediatric Society, the European Society for Paediatric Research, and the Society for Pediatric Research. The study demonstrates the clinical potential of Seed Health's first pediatric synbiotic offering, PDS-08™ Pediatric Daily Synbiotic, in children with intermittent constipation. Christopher E. Mason, Ph.D., Professor of Physiology and Biophysics at Weill Cornell Medicine, led the bioinformatics analysis, including the generation of novel insights into the role of the gut microbiome in pediatric gastrointestinal (GI) health.

Key Points: 
  • The study demonstrates the clinical potential of Seed Health's first pediatric synbiotic offering, PDS-08 Pediatric Daily Synbiotic , in children with intermittent constipation.
  • Children with intermittent constipation (less than five weekly bowel movements, or WBMs) experienced an increase in regular, healthy WBMs while taking PDS-08 .
  • "These findings represent the next frontier in probiotics and deepen our understanding of the pediatric gut microbiome."
  • LUCA Biologics , Seed Health's biotechnology company co-founded with Dr. Jacques Ravel, develops living medicines targeting the vaginal microbiome for urogenital and reproductive health.

Grameen Foundation names Zubaida Bai President and CEO: Bai and new board members to lead Grameen Foundation into its second quarter-century

Retrieved on: 
Tuesday, November 1, 2022

WASHINGTON, Nov. 1, 2022 /PRNewswire-PRWeb/ -- Grameen Foundation, a leader in providing access to information and resources with a mission to create a world without poverty and hunger, today announced Zubaida Bai as its next President and CEO. She is the first woman and the first Indian American to lead the organization.

Key Points: 
  • Bai comes to Grameen Foundation with over 18 years in the social impact space.
  • "We are delighted to welcome Zubaida Bai as CEO," said Marianne Udow-Phillips, Grameen Foundation board member and chair of the CEO search committee.
  • Zubaida is the ideal person to lead Grameen Foundation into its next quarter-century of impact."
  • Grameen Foundation also announced the appointments of Lauren Hendricks, Gopi Kallayil, and Jeffrey Scott to the board of directors.